4//SEC Filing
Biller Jonathan 4
Accession 0001439222-22-000031
CIK 0001439222other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:12 PM ET
Size
7.8 KB
Accession
0001439222-22-000031
Insider Transaction Report
Form 4
Biller Jonathan
Chief Legal Officer
Transactions
- Award
Stock options (right to buy)
2022-03-01+41,000→ 41,000 totalExercise: $32.20Exp: 2032-03-01→ Common stock (41,000 underlying) - Award
Restricted stock units
2022-03-01+11,500→ 11,500 total→ Common stock (11,500 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.
- [F3]This option was granted on March 1, 2022. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001744749
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:12 PM ET
- Size
- 7.8 KB